BioLineRx Ltd. (BLRX)
NASDAQ: BLRX
· Real-Time Price · USD
3.75
-0.02 (-0.53%)
At close: Aug 15, 2025, 3:59 PM
3.77
0.53%
After-hours: Aug 15, 2025, 07:16 PM EDT
BioLineRx Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -3.4M | -9.22M | -19.92M | -30.12M | -49.15M | -60.61M | -52.46M | -43.28M | -32.18M | -24.95M | -23.52M | -22.39M | -21.79M | -27.05M | -34.74M | -33.64M | -33.57M |
Depreciation & Amortization | 3.33M | 4.07M | 2.92M | 2.3M | 2.02M | 1.38M | 865K | 797K | 740K | 654K | 641K | 655K | 694K | 703K | 726K | 763K | 795K |
Stock-Based Compensation | 796K | 1.14M | 2.22M | 2.37M | 2.42M | 2.32M | 2.44M | 2.58M | 2.42M | 2.25M | 1.59M | 1.25M | 1.28M | 1.5M | 1.26M | 1.18M | 1.08M |
Other Working Capital | -12.5M | -18.51M | -1.26M | 4.36M | 9.52M | 17.15M | 3.11M | -425K | 1.34M | 1.07M | 175K | 2.23M | 1.42M | 1.42M | 1.04M | n/a | 92K |
Other Non-Cash Items | -21.52M | -18.03M | -12.47M | -9.63M | -2.95M | 4.3M | 3M | 297K | -990K | -5.43M | -3M | -1.42M | -1.27M | 39K | 141K | 450K | 361K |
Deferred Income Tax | n/a | n/a | 3.68M | 6.83M | 14.8M | 14.8M | 11.12M | 7.97M | n/a | n/a | -2.34M | -3.11M | -2.95M | 1.78M | 9.89M | 10.19M | 10.88M |
Change in Working Capital | -11.56M | -21.82M | -6.7M | -2.1M | 4.16M | 15.2M | 1.76M | -425K | 1.34M | 1.24M | 572K | 2.63M | 1.11M | -540K | -783K | -2.9M | -2.25M |
Operating Cash Flow | -32.35M | -43.87M | -30.27M | -30.35M | -28.7M | -22.61M | -33.28M | -32.06M | -28.67M | -26.24M | -26.06M | -22.39M | -22.93M | -23.57M | -23.5M | -23.96M | -22.7M |
Capital Expenditures | -21K | -53K | -77K | -104K | -200K | -297K | -507K | -506K | -427K | -316K | -150K | -121K | -96K | -97K | -34K | -37K | -19K |
Cash Acquisitions | n/a | n/a | 2K | 28K | 84K | 77.33K | 71.41K | 60.33K | -5.75K | 929.00 | 4.85K | -10.07K | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -38.66M | -26.35M | -60.06M | -62.14M | -42.09M | -47.59M | -21.88M | -41.01M | -42.5M | -44M | -44M | -29M | -43M | -78M | -75M | -67.75M | -69.5M |
Sales Maturities Of Investments | 43.19M | 55.78M | 57.95M | 53.99M | 53.78M | 49.33M | 48.09M | 48.18M | 48.53M | 48.32M | 48.29M | 48.24M | 46.18M | 39.87M | 41.35M | 41.61M | 43.73M |
Other Investing Acitivies | -1K | -1K | -2K | -28K | -84K | -77.33K | -71.41K | -60.33K | 5.75K | -929 | -4.85K | -24.93K | -35K | -35K | -35K | n/a | n/a |
Investing Cash Flow | 4.51M | 29.37M | -2.18M | -8.26M | 11.49M | 1.44M | 25.7M | 6.67M | 5.6M | 4.01M | 4.14M | 19.12M | 3.08M | -38.22M | -33.68M | -26.18M | -25.78M |
Debt Repayment | -15.3M | -14.94M | -3.7M | -3.61M | -2.83M | -1.99M | -1.22M | 8.35M | 7.52M | 6.63M | 5.8M | -3.7M | -3.65M | -3.57M | -3.5M | -3.67M | -3.5M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 24.81M | 24.81M | 25.23M | 27.74M | 2.96M | 2.96M | 1.99M | -553K | -551K | -551K | 2K | 2K | 10.91M | 10.91M | 10.91M | 10.91M | 6K |
Financial Cash Flow | 31M | 20.66M | 33.51M | 38.22M | 14.21M | 15.06M | 2.67M | 21.89M | 21.33M | 20.44M | 21.26M | 117K | 14.9M | 57.75M | 64.52M | 61.9M | 59.39M |
Net Cash Flow | 3.05M | 6.18M | 1.11M | -481K | -3.08M | -6.33M | -5.38M | -3.9M | -2.38M | -2.4M | -972K | -3.48M | -4.6M | -3.84M | 7.53M | 11.96M | 10.97M |
Free Cash Flow | -32.38M | -43.93M | -30.35M | -30.45M | -28.9M | -22.91M | -33.79M | -32.57M | -29.1M | -26.56M | -26.21M | -22.51M | -23.03M | -23.67M | -23.54M | -24M | -22.72M |